3/31/2023  4:59:45 PM Chg. +4.20 Volume Bid4:59:45 PM Ask4:59:45 PM Market Capitalization Dividend Y. P/E Ratio
902.00DKK +0.47% 89,992
Turnover: 34.61 mill.
-Bid Size: - -Ask Size: - 175.67 bill.DKK 2.11% 39.78

Business description

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Coloplast's business includes ostomy care, urology and continence care, and wound and skin care.
 

Management board & Supervisory board

CEO
Kristian Villumsen
Management board
Anders Lonning-Skovgaard, Allan Rasmussen, Camilla G. Møhl, Nicolai Buhl Andersen, Paul Marcun
Supervisory board
Lars Rasmussen, Annette Brüls, Carsten Hellmann, Jette Nygaard-Andersen, Marianne Wiinholt, Niels Peter Louis-Hansen, Nikolaj Kyhe Gundersen, Roland Vendelbo Pedersen, Thomas Barfod
 

Company data

Name: Coloplast Group
Address: Holtedam 1-3,DK-3050 Humlebaek
Phone: +45-4911-1111
Fax: -
E-mail: coloplast@colopolast.com
Internet: www.coloplast.com/
Industry: Commodities
Sector: Chemicals
Sub sector: -
End of financial year: 9/30
Free Float: 64.10%
IPO date: -

Investor relations

Name: Ellen Bjurgert
IR phone: +45-4911-3376
IR Fax: +45-4911-1555
IR e-mail: dkebj@coloplast.com

Company calendar

CW 19 | 5/11/2023 Interim Report 2nd Quarter/6 Months
CW 33 | 8/17/2023 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
64.10%
Niels Peter Louis-Hansen
 
20.70%
Aage og Johanne Louis-Hanses Fond
 
11.50%
Benedicte Find
 
3.70%